NCT04784767 PHASE 1 SARS-COV-2-Spike-Ferritin-Nanoparticle (SpFN) Vaccine With ALFQ Adjuvant for Prevention of COVID-19 Status COMPLETED Phase PHASE1
NCT04784403 SCREENING AND SEROEPIDEMIOLOGY OF SARS-CoV-2 INFECTION AT THE UNIVERSITY OF BARCELONA: A CROSS-SECTIONAL STUDY Status COMPLETED Phase N/A
NCT04778059 Safety and Efficacy of USB002 for Respiratory Distress Due to COVID-19 Status TERMINATED Phase PHASE2
NCT04757818 Double-blind, Randomized, Parallel, Placebo-controlled Clinical Study to Evaluate the Viral Load of SARS-CoV-2 (COVID-19) in the Oral Cavity of SARS-CoV-2 Positive Subjects After the Use of a Mouthwash Containing Cetylpyridinium Chloride 0,07%. Status COMPLETED Phase NA
NCT04754594 To Evaluate the Safety, Tolerability, and Immunogenicity of BNT162b2 Against COVID-19 in Healthy Pregnant Women 18 Years of Age and Older Status COMPLETED Phase PHASE2/PHASE3
NCT04739020 Respiratory Aerosols in Patients With COVID-19 and Healthy Controls Status UNKNOWN Phase NA
NCT04738695 SARS-CoV-2 Seroprevalence Among Nursing Home Staff and Residents (COVID-19) Status COMPLETED Phase N/A
NCT04738136 Safety, Tolerability and Efficacy Of S-1226 in Moderate Severity Covid-19 Bronchiolitis/Pneumonia Status SUSPENDED Phase PHASE2
NCT04721535 A Study of DWJ1248 in Prevention of COVID-19 Infection After the Exposure of SARS-COV-2 Status TERMINATED Phase PHASE3
NCT04715360 Management of Cytokine Storms in Severe COVID-19 Patients With Autologous Activated Platelet-rich Plasma Therapy Status UNKNOWN Phase PHASE1/PHASE2
NCT04713553 A Phase 3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of Multiple Production Lots and Dose Levels of BNT162b2 RNA-Based COVID-19 Vaccines Against COVID-19 in Healthy Participants Status COMPLETED Phase PHASE3
NCT04710394 Visual-OLfactory Training in Participants With COVID-19 Resultant Loss of Smell Status COMPLETED Phase NA
NCT04681430 Reconvalescent Plasma/Camostat Mesylate Early in SARS-CoV-2 Q-PCR (COVID-19) Positive High-risk Individuals Status COMPLETED Phase PHASE2
NCT04661930 Fenofibrate for Patients With COVID-19 Requiring Hospitalization Status UNKNOWN Phase PHASE3
NCT04647305 Effectiveness and Adherence to Closed Face Shields to Prevent COVID-19 Transmission Status COMPLETED Phase NA
NCT04643548 WHO Covid 19 - Neurological Abnormalities in SARS-CoV-2 ICU Patients Status UNKNOWN Phase N/A